OLMESARTAN MEDOXOMIL for Renin-angiotensin system inhibition: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where OLMESARTAN MEDOXOMIL was used for Renin-angiotensin system inhibition.
Most Reported Side Effects for OLMESARTAN MEDOXOMIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Sprue-like enteropathy | 3,482 | 29.1% | 50 | 2,625 |
| Gastrooesophageal reflux disease | 1,819 | 15.2% | 19 | 1,304 |
| Acute kidney injury | 1,587 | 13.3% | 47 | 1,423 |
| Weight decreased | 1,569 | 13.1% | 11 | 1,192 |
| Haemorrhoids | 1,316 | 11.0% | 13 | 965 |
| Diarrhoea | 1,300 | 10.9% | 16 | 753 |
| Hiatus hernia | 938 | 7.8% | 21 | 719 |
| Dizziness | 885 | 7.4% | 5 | 500 |
| Large intestine polyp | 839 | 7.0% | 12 | 618 |
| Constipation | 796 | 6.7% | 14 | 563 |
| Hypotension | 794 | 6.6% | 22 | 591 |
| Diverticulum | 770 | 6.4% | 9 | 611 |
| Diverticulitis | 742 | 6.2% | 10 | 550 |
| Malabsorption | 689 | 5.8% | 11 | 326 |
| Diverticulum intestinal | 641 | 5.4% | 8 | 472 |
Other Indications for OLMESARTAN MEDOXOMIL
Hypertension (5,702)
Product used for unknown indication (5,242)
Essential hypertension (166)
Blood pressure measurement (110)
Blood pressure management (87)
Blood pressure abnormal (77)
Blood pressure increased (45)
Blood pressure (24)
Foetal exposure during pregnancy (20)
Cardiac disorder (15)